With some tweaks, CAR-T cancer therapy could be made safer — and more widely available — study suggests

Monday, April 22, 2019

STAT – In a small clinical trial, patients treated with a slightly modified version of an approved CAR-T saw benefits on par with previous studies but with none of the hallmark side effects that can leave some patients hospitalized and in need of costly extra treatments.